The Company is a Korea-based company primarily engaged in provision of drug development supporting services and pharmaceutical product QC services. The Company s services include bioequivalence study, drug analysis, metabolites analysis, heavy metal analysis, toxic substance analysis, toxicant test, QC test for imported products, dissolution test and TK study. The Company was founded on January 17, 2007. and its shares are listed on KOREA NEW EXCHANGE(KONEX) on Jun 29, 2016.
Headquarters
107,Gwanggyo-Ro, Yeongtong-Gu
Suwon; Gyeonggi;
Contact Details: Purchase the Sls Bio Co. Ltd. report to view the information.
Website: http://www.slabs.co.kr
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service